Translate Bio Funding: $136M Raised, Series C (2017)
Translate Bio is based in Paris, France. It has raised $136M in total funding. Latest round: Series C. Backed by Atlas Venture.
Translate Bio funding overview
Translate Bio is based in Paris, France. Translate Bio has raised $136M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in January 2017. The round record for Translate Bio runs through 2017; nothing later has been disclosed. Investors on record include Atlas Venture.
Translate Bio at a glance
Total raised
$136M
Latest round
Series C
Latest round date
January 2017
Headquarters
Paris, France
Notable investors
Atlas Venture
Frequently asked about Translate Bio funding
How much has Translate Bio raised?
Translate Bio has raised $136M in total disclosed funding across the rounds on record.
Who has invested in Translate Bio?
Atlas Venture are named among the investors backing Translate Bio.
What was the latest Translate Bio funding round?
The most recent disclosed round is a Series C, announced in January 2017.
Where is Translate Bio based?
Translate Bio is based in Paris, France.
When did Translate Bio last raise?
The last disclosed Translate Bio round closed in January 2017 at Series C.
Totals shown for Translate Bio aggregate every disclosed round on file. To see how that compares, browse the companies in Paris and the investors behind them below.
